Cancer Biomarkers Market by Biomarker Type (Genetic Biomarkers, Protein Biomarkers, and Other Biomarkers); by Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer, and Other Cancer Types); by Profiling Technology (Imaging technologies, Omic Technologies (Proteomics, Genomics, and Other Omic Technologies), Cytogenetics-Based Tests, and Immunoassays); and for Application (Drug discovery and Development, Personalized medicine, Diagnostics, and Other Applications): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Global cancer biomarkers market expected to generate revenue of around USD 26,000 million by end of 2024, growing at a CAGR of around 13% between 2018 and 2024. Cancer biomarkers are perceptible substances, that are used as an indicator of the biological status of the tumor and hence they are used to analyze the prognostic and diagnostic stages of cancer.

01-Oct-2018 | Number of pages: 140 | Report Code: ZMR-2641 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the cancer biomarkers market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the cancer biomarkers market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cancer biomarkers market on a global level.

In order to give the users of this report a comprehensive view of the cancer biomarkers market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein biomarker type segment, cancer type segment, , and profiling technology segment are benchmarked based on their market size, growth rate, and general attractiveness.

Global Cancer Biomarkers Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new cancer type launch, agreements, partnerships, collaborations & joint ventures, research & development, cancer type, and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, product portfolio of various companies according to region.

The study provides a decisive view of the cancer biomarkers market by segmenting the market based on biomarker type segment, cancer type, and profiling technology, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on biomarker type the global cancer biomarkers market is segmented as genetic biomarkers, protein biomarkers, and other biomarkers. Based on cancer type, the market is segmented as breast cancer, colorectal cancer, lung cancer, prostate cancer, blood cancer, melanoma, ovarian cancer, liver cancer, stomach cancer, and other cancer types. By profiling technology, the cancer market is further segmented as imaging technologies, omic technologies, cytogenetics-based tests, and immunoassays. The omic technologies segment is further segmented as genomics, proteomics, and other omic technologies. Based on applications, the cancer biomarkers market segmented as drug discovery and development, personalized medicine, diagnostics, and other applications. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa and Rest of Middle East and Africa. 

The report also includes detailed profiles of end players such as Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Agilent Technologies, QIAGEN, Illumina, Inc., QIAGEN, Sino Biological Inc., Merck & Co., Inc., Novartis AG, Hologic, Inc., bioMérieux SA, Genomic Health, Inc.

This report segments the global cancer biomarkers market as follows:

Global Cancer Biomarkers Market: Biomarker Type Segment Analysis

  • Genetic Biomarkers 
  • Protein Biomarkers 
  • Other Cancer Biomarkers

Global Cancer Biomarkers Market: Cancer Type Segment Analysis

  • Breast Cancer 
  • Lung Cancer 
  • Prostate Cancer 
  • Colorectal Cancer 
  • Blood Cancer
  • Melanoma 
  • Ovarian Cancer
  • Liver Cancer
  • Stomach Cancer
  • Other Cancer Types 

Global Cancer Biomarkers Market: Profiling Technology Segment Analysis

  • Imaging technologies
  • Omic Technologies
    • Proteomics
    • Genomics
    • Other Omic technologies
  • Cytogenetics-Based Tests
  • Immunoassays

Global Cancer Biomarkers Market: Applications  Segment Analysis

  • Drug discovery and Development
  • Personalized medicine
  • Diagnostics
  • Others

Global Cancer Biomarkers Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Apoptosis Assays Market by Product (Assay Kit, Reagent, Instruments, and Microplates), By Detection Technology (Flow Cytometry, Fluorescence Microscopy, and Others), By Application (Drug Discovery and Development, Clinical Research, Stem Cell Research, and Basic Research), and by End-User (Pharmaceutical and Biotechnology Companies, Diagnostic Labs, Hospitals, and Academic and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Jun-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-4217 | Report Format:

The report covers a forecast and an analysis of the apoptosis assays market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the apoptosis as...Read More

RNA Based Therapeutics Market by Technology (Enabled Technology and Enabling Technology), by Application (Kidney Diseases, Cardiovascular, Metabolic Disorders, Infectious Diseases, Oncology, and Others), and by End-User (Research, Diagnosis, Therapeutics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Jun-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-4192 | Report Format:

The report covers a forecast and an analysis of the RNA based therapeutics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the RNA based ...Read More

NGS Sample Preparation Market by Workflow (Target Enrichment and Library Preparation), by Product (Consumables & Reagents and Workstations), Technology (Nanopore Sequencing, Sequencing by Synthesis, Single Molecule Real Time Sequencing, and Ion Semiconductor Sequencing), and by Application (Drug Discovery, Animal & Agricultural Research, Diagnostics, Precision Medicine, Biomarker Discovery, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

May-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-4162 | Report Format:

The report covers a forecast and an analysis of the NGS sample preparation market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the NGS sample...Read More

Nutrigenomics Market by Product Type (Reagents and Kits and Services) and by Application (Cardiovascular Diseases, Obesity, Cancer, and Other Chronic Diseases): Global Market Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Jul-2019 | Price : $ 4899.00 | Pages: 120 | Report Code: ZMR-4112 | Report Format:

The report covers a forecast and an analysis of the global nutrigenomics market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD million). The study includes drivers and restraints of the global nutri...Read More

Biotech Ingredients Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-4065 | Report Format:

Global Biotech Ingredients Market: Overview Biotech ingredients are large and complex drugs that are structurally identical to compounds found in natural organisms. These medical drugs are produced using complex biotechnological processes, such as genetic engineering and hybridoma technology as ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.